Targeting the environmental risk assessment of pharmaceuticals: Facts and fantasies

Integrated Environmental Assessment and Management

Volumn 6, Issue SUPPL. 1, 2010, Pages 603-613

  Tarazona, Jose V ^a   Escher, Beate I ^b   Giltrow, Emma ^c   Sumpter, John ^c   Knacker, Thomas ^d  

^a INIA   (Spain)

^b SWISS FEDERAL INSTITUTE OF AQUATIC SCIENCE AND TECHNOLOGY   (Switzerland)

^c BRUNEL UNIVERSITY   (United Kingdom)

^d KECT Oekotoxikologie GmbH   (Germany)

Author keywords

Environmental risk assessment; Multispecies tests; Pharmaceuticals; Pharmacology; Targeted risk assessment

Indexed keywords

DRUG; WATER;

ANIMAL; ARTICLE; CHEMISTRY; METABOLISM; METHODOLOGY; PHARMACOECONOMICS; PHARMACOKINETICS; PHYSICAL CHEMISTRY; POLLUTANT; PRACTICE GUIDELINE; RISK ASSESSMENT; SOIL;

ANIMALS; ECONOMICS, PHARMACEUTICAL; ENVIRONMENTAL POLLUTANTS; GUIDELINES AS TOPIC; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHYSICOCHEMICAL PROCESSES; RISK ASSESSMENT; SOIL; WATER;

EID: 77956361103     PISSN: 15513793     EISSN: None     Source Type: Journal    
DOI: 10.1897/IEAM-2009-052.1     Document Type: Article

References (74)

1. Austin RP, Barton P, Davis AM, Manners C, Stansfield MC. 1998. The effect of ionic strength on liposome-buffer and 1-octanol-buffer distribution coefficients. Pharm Sci 87: 599-607
2. Avdeef A, Box KJ, Comer JEA, Hibbert C, Yam KY. 1998. pH-metric log P 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs. Pharm Res 15: 209-215
3. Avdeef A, Artursson P, Neuhoff S, Lazorova L, Grasjo J, Tavelin S. 2005. CACO-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pK flux method. Eur J Pharm Sci 24: 333-349
4. Boleas S, Alonso C, Pro J, Bab́in MM, Fernandez C, Carbonell G, Tarazona JV. 2005a. Effects of sulfachlorpyridazine in MS -3-arable land: a multispecies soil system for assessing the environmental fate and effects of veterinary medicines. Environ Toxicol Chem 24: 811-819
5. Boleas S, Alonso C, Pro J, Fernandez C, Carbonell G, Tarazona JV. 2005b. Toxicity of the antimicrobial oxytetracycline to soil organisms in a multispecies-soil system (MS-3) and influence of manure co-addition. J Hazard Mater 122: 233-241
6. Brock CM, Alix A, Brown CD, Capri E, Gottesburen BFF, Heimbach F, Lythgo CM, Schulz R, Streloke M, 2010. Linking aquatic exposure and effects-Risk assessment of pesticides. Boca Raton (FL): CRC. 410 p
7. Campbell PJ, Arnold DJS, BrockTCM, Grandy NJ, Heger W, Heimbach F, Maund SJ, Streloke M. 1999. HARAP guidance document: higher-tier aquatic risk assessment for pesticides. Brussels (BE): SETAC Europe. 179 p.
8. Checkai RT, Wentsel RS, Phillips CT, Yon RL. 1993. Controlled environment soil-core microcosm unit for investigating fate, migration, and transformation of chemicals in soils. J Soil Contam 2: 229-243.
9. Comer J, Tam K. 2000. Lipophilicity profiles: theory and measurement. In: Testa B, Waterbeemd V, Folkers G, Guy R, editors. Pharmacokinetic optimization in drug research: biological, physicochemical, and computational strategies. Zurich (CH): VHCA. p 275-304.
10. Crane M, Watts C, Boucard T. 2006. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci Tot Environ 367: 23-41.
11. [DG SANCO] Directorate General for Health and Consumer Affairs. 2002a. Guidance document on aquatic ecotoxicology under Council Directive 91/ 414/EEC. DG SANCO. 3268/2001.rev4 final.
12. [DG SANCO] Directorate General for Health and Consumer Affairs. 2002b. Guidance document on terrestrial ecotoxicology under Council Directive 91/414/EEC. DG SANCO. 10329/2002rev.2 final.
13. [EC] European Commission. 2003. Technical guidance document on risk assessment in support of Commission Directive 93/67/EEC on risk assessment of new notified substances, Commission Regulation (EC) No 1488/94 on risk assessment for existing substances and Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market. Ispra (IT): European Commission Joint Research Centre. EUR 20418 EN.
14. Edwards CA, Knacker T, Pokarzhevskii A, Subler S, Parmelee R. 1996. The use of soil microcosms in assessing the effects of pesticides on soil ecosystems. In: Environmental behaviour of crop protection chemicals. Proceedings of an international symposium on the use of nuclear and related techniques for studying environmental behaviour of crop protection chemicals; 1996 July 1-5. Vienna, Austria: International Atomic Energy Agency and Food and Agriculture Organization of the United Nations. p 437-451.
15. [EMEA/CHMP] European Medicines Agency/Committee for Medicinal Products for Human Use. 2006. Guideline on the environmental risk assessment of medicinal products for human use. London, UK: EMEA. EMEA/CHMP/SWP/ 4447/00.
16. [EMEA/CVMP] European Medicines Agency/Committee for Medicinal Products for Veterinary Use. 2008. Revised guideline on environmental impact assessment for veterinary medicinal products in support of the VICH guidelines GL6 and GL38. London, UK: EMEA. EMEA/CVMP/ERA/418282/2005-Rev.1 Consultation.
17. Erickson RJ, McKim JM, Lien GJ, Hoffman AD, Batterman SL. 2006a. Uptake and elimination of ionizable organic chemicals at fish gills: I. Model formulation, parameterization, and behaviour. Environ Toxicol Chem 25: 1512-1521.
18. Erickson RJ, McKim JM, Lien GJ, Hoffman AD, Batterman SL. 2006b. Uptake and elimination of ionizable organic chemicals at fish gills: II. Observed and predicted effects of pH, alkalinity, and chemical properties. Environ Toxicol Chem 25: 1522-1532.
19. Escher BI, Schwarzenbach RP, Westall JC. 2000. Evaluation of liposome-water partitioning of organic acids and bases: I. Development of sorption model. Environ Sci Technol 34: 3954-3961.
20. Escher BI, Schwarzenbach RP. 2002. Mechanistic studies on baseline toxicity and uncoupling as a basis for modeling internal lethal concentrations in aquatic organisms. Aquat Sci 64: 20-35.
21. Escher BI, Sigg L. 2004. Chemical speciation of organics and of metals at biological interfaces. In: Van Leeuwen HP, Köster W, editors. Physicochemical kinetics and transport at biointerface. Chichester (UK): John Wiley & Sons. p 205- 271.
22. Escher BI, Bramaz N, Mueller JF, Quayle P, Rutishauser S. 2008. Toxic equivalent concentrations (TEQs) for baseline toxicity and specific modes of action as a tool to improve evaluation of ecotoxicity tests on environmental samples. J Environ Monitor 10: 612-621.
23. Escher BI, Baumgartner R, Lienert J, Fenner K. 2009. Predicting the ecotoxicological effects of transformation products. In: Boxall A, editor. Handbook of environmental chemistry-degradation of synthetic chemicals in the environment. Heidelberg (DE): Springer. p 205-244. DOI: 10.1007/698-2-015.
24. Fent K, Weston A, Caminada D. 2006. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76: 122-159.
25. Fernandez C, Alonso C, Babin MM, Pro J, Carbonell C, Tarazona JV. 2004. Ecotoxicological assessment of doxycycline in aged pig manure using multispecies soil systems (MS-3). Sci Total Environ 323: 63-69.
26. Fredrickson JK, Van Voris P, Bentjen SA, Bolton H Jr. 1991. Terrestrial microcosm for evaluating the environmental fate and risks associated with the release of chemicals or genetically engineered micro-organisms to the environment. Toxic Subst J 11: 65-110.
27. Fujita T. 1966. The analysis of physiological activity of substituted phenols with substituent constants. J Med Chem 9: 797-803.
28. Garric J, Vollat B, Duis K, Pery A, Junker T, Ramil M, Fink G, TernesTA. 2007. Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata. Chemosphere 69: 903-910.
29. Giddings JM, Brock TM, Heger W, Heimbach F, Maund SJ, Norman SM, Ratte HT, Schafers C, Streloke M, 2002. Community-level aquatic system studies- interpretation criteria (CLASSIC). Pensacola (FL): SETAC. 60 p.
30. GiesyJPJr, Odum EP 1980. Microcosmology: introductory comments. In: GiesyJP Jr. editor. Microcosms in ecological research. Springfield (VA): Technical Information Center, US Department of Energy. p 1-13.
31. Gillett JW, Witt J-M. 1979. Terrestrial microcosms. Workshop proceedings; 1977, 13-14 June, Corvallis, Oregon: National Science Foundation, Washington DC. Report NSF/RA-790034.
32. GoksørA, Forlin L. 1991. The cytochrome P-450 system in fish, aquatic toxicology and environmental monitoring. Aquat Toxicol 22: 287-312.
33. Hansch C, Leo A. 1995. Exploring QSAR. Fundamentals and applications in chemistry and biology. Washington DC: American Chemical Society. 557 p.
34. Hermens JLM, Verhaar HJM. 1995. QSARs in environmental toxicology and chemistry. In: Hansch C, Fujita T, editors. Classical and three-dimensional QSAR in agrochemistry Washington DC: American Chemical Society. p 130- 140.
35. Huggett DB, Cook JC, Ericson JF, Williams RT 2003. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum Ecol Risk Assess 9: 1789-1799.
36. Huggett DB, Benson WH, Chipman K, Cook JC, Gray LE, Kinter LB, Meyerhoff RD, Trudeau VI. 2005. Role of mammalian data in determining pharmaceutical responses in aquatic species. Pensacola (FL): SETAC. p 149-181.
37. Jafvert CT, Westall JC, Grieder E, Schwarzenbach RP. 1990. Distribution of hydrophobic ionogenic compounds between octanol and water: organic acids. Environ Sci Technol 24: 1795-1803.
38. Johnson CA, Westall JC. 1990. Effect of pH and KCl concentration on the octanol-water distribution of methylanilines. Environ Sci Technol 24: 1869-1875.
39. Knacker T, Van Gestel CAM, Jones SE, Soares AMVM, Schallnass H-J, Forster B, Edwards CA. 2004. Ring-testing and field-validation of a terrestrial model ecosystem (TME)-an instrument for testing potentially harmful substances: Conceptual approach and study design. Ecotoxicology 13: 5-23.
40. Kramer S. 2001. Liposome/water partitioning: theory, techniques, and applications. In: Testa B, Waterbeemd V, Folkers G, Guy R, editors. Pharmacokinetic optimization in drug research: biological, physicochemical, and computational strategies. Zurich (CH): VHCH. p 401-428.
41. Kuster A, Alder AC, Escher B, Duis K, Fenner K, Garric J, Hutchinson T, Lapen DR, Pery A, Rombke J, Snape J, Ternes T, Topp E, Wehrhan A, Knacker T 2010. Environmental risk assessment of human pharmaceuticals in the European Union - A case study with the b-blocker atenolol. Integr Environ Assess Manag 6:514-523 (this issue).
42. Kwon J-H, Katz LE, Liljestrand HM. 2006. Use of a parallel artificial membrane system to evaluate passive absorption and elimination in small fish. Environ Toxicol Chem 25: 3083-3092.
43. Kwon J-H, Escher BI. 2008. A modified parallel artificial membrane permeability assay for evaluating bioconcentration of highly hydrophobic chemicals in fish. Environ Sci Technol 42: 1787-1793.
44. Liebig M, Moltmann JF, Knacker T 2006. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products. Environ Sci Pollut Res 13:110-119.
45. Liebig M, Schmidt G, Bontje D, Kooi BW, Streck G, Traunspurger W, Knacker T 2008. Direct and indirect effects of pollutants on algae and algivorous ciliates in an aquatic indoor microcosm. Aquat Toxicol 88: 102-110.
46. Liebig M, Alonso Fernandez A, Blübaum-Gronau E, Boxall A, Egeler P, Fenner K, Fink G, Garric J, Halling-Sørensen B, Jensen J, Knacker T, Krogh KA, Küster A, Löffer D, Moldan N, Pope L, Prasse C, Römbke J, Rönnefahrt I, Sánchez Argüello P, Schneider MK, Tarazona JV, Ternes TA, Wehrhan A,DuisK. 2010. Environmental risk assessment of veterinary pharmaceuticals-ivermectin as a case study. Integr Environ Assess Manag 6:567-587 (this issue).
47. Lienert J, Güdel K, Escher BI. 2007. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ Sci Technol 41: 4471-4478.
48. Montforts MHMM Backwell P, Boxall A, Halling-Sørensen B, Hermansen S, Ingerslev F, Jacobsen AM, Kay P, ter Laak T, Moltmann J, Schmitt H, Soeborg T, Tarazona JV, Tolls J, Verschoor A. 2003. Environmental risk assessment for veterinary medicinal products. Part 5. A guide to risk assessment of veterinary medicinal products used in animal husbandry. Bilthoven (NL): RIVM. Report 601450018/ 2003.
49. Morgan E, Knacker T. 1994. The role of laboratory terrestrial model ecosystems in the testing of potentially harmful substances. Ecotoxicology 3: 213-233.
50. Nendza M, Russom C. 1991. QSAR modeling of the ERL-D fathead minnow acute toxicity database. Xenobiotica 21: 147-170.
51. Oakes K, Coors A, Escher B, Fenner K, Garric J, Gust M, Knacker T, Küster A, Kussatz C, Metcalfe C, Monteiro S, Moon T, Parrott J, Pery A, Ramil M, Tarazona JV, Sánchez Argüello P, Ternes T, Trudeau V, Van Der Kraak G, Servos M. An environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine - A case study utilizing the European risk sssessment framework. Integr Environ Assess Manag 6:524-539 (this issue).
52. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, Shivaprasad HL, Ahmed S, Iqbal Chaudhry MJ, Arshad M, Mahmood S, Ali A, Ahmed Khan A. 2004. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427: 630-633.
53. [OECD] Organisation for Economic Co-operation and Development. 2006. Guidance document on simulated freshwater lentic field tests (outdoor microcosms and mesocosms). OECD series on testing and assessment No. 53. Paris (FR): OECD. ENV/JM/MONO(2006)17.
54. Purdom CE, Hardiman PA, Bye VA, Eno NC, Tyler CR, Sumpter JP. 1994. Estrogenic effects of effluents from sewage treatment works. Chem Ecol 8: 275-285.
55. Sanchez P, Tarazona JV. 2002. Development of a multispecies system for testing reproductive effects on aquatic invertebrates. Experience with Daphnia magna, Chironomus prasinus and Lymnaea peregra. Aquatic Toxicol 60: 249-256.
56. Sanderson H, Laird B, Pope L, Brain R, Wilson C, Johnson D, Bryning G, Peregrine AS, Boxall A, Solomon K. 2007. Assessment of the environmental fate and effects of ivermectin in aquatic mesocosms. Aquat Ecotoxicol 85: 229-240.
57. Scherrer RA. 1984. The treatment of ionizable compounds in quantitative structure-activity studies with special consideration to ion partitioning. In: Magee PS, Kohn GK, Menn JJ, editors. Pesticide synthesis through rational approaches. ACS Symposium Series 255. Washington DC: ACS. p 225- 246.
58. Schmitt H, Boucard T, Garric J, Jensen J, Parrott J, Péry A, Römbke J, Straub JO, Hutchinson T, Sánchez P, Wennmalm A, Duis K. Recommendations on the environmental risk assessment of pharmaceuticals: Effect characterization. Integr Environ Assess Manag 6:588-602 (this issue)
59. Schramm K-W, Jaser W, Welzl G, Pfister G, Wöhler-Moorhoff GF, Hense BA. 2008. Impact of 17a-ethinylestradiol on the plankton in freshwater microcosms-I: Response zooplankton and abiotic varables. Ecotoxicol Environ Saf 69: 437-452
60. Schwarzenbach RP, Gschwend PM, Imboden DM. 2003. Environmental organic chemistry. 2nd ed. New York (NY): John Wiley & Sons. 1313 p.
61. [SSC] Scientific Steering Committee. 2003. Second report on the harmonization of risk assessment protocols. Brussels (BE): SSC, European Commission
62. Tarazona JV, Hund K, Jager T, S-Salonen M, Soares AMVM, Skaare JU, Vigui M. 2002. Standardizing chemical risk assessment, at last. Nature 415: 14
63. Tarazona JV, Vega MM. 2002. Hazard and risk assessment of chemicals for terrestrial ecosystems. Toxicology 181/182: 187-191
64. Tarazona JV, Buzby ME, Hartmann A, Housenger JE, Olejniczak K, Sager NB, Servos MR, Tolson ND. 2005. Scientific basis for aquatic environmental risk assessment of human pharmaceuticals. In: Williams RT, editor. Human pharmaceuticals: assessing the impacts on aquatic ecosystems. Pensacola (FL): SETAC. p 269-302
65. Testa B, Krämer S, Wunderli-Allenspach H, Folkers G. 2006. Pharmacokinetic profiling in drug research: biological, physicochemical, and computational strategies. Zurich (CH): VHCA, 500 p.
66. Thorpe KL, Cummings RI, Hutchinson TH, Scholze M, Brighty G, Sumpter JP, Tyler CR. 2003. Relative potencies and combination effects of steroidal estrogens in fish. Environ Sci Technol 37: 1142-1149
67. Vaes WHJ, Urrestarazu-Ramos E, Verhaar HJM, Cramer CJ, Hermens JLM. 1998a. Understanding and estimating membrane/water partition coefficients: approaches to derive quantitative structure property relationships. Chem Res Toxicol 11: 847-854
68. Vaes WHM, Urrestarazu-Ramos E, Verhaar H, Hermens JLM. 1998b. Acute toxicity of nonpolar versus polar narcosis: is there a difference? Environ Toxicol Chem 17: 1380-1384
69. Van den Brink PJ, Tarazona JV, Solomon K,Knacker T, Van den Brink NW, Brock TCM, Hoogland JP. 2005. The use of terrestrial and aquatic microcosms and mesocosms for the ecological risk assessment of veterinary medicinal products. Environ Toxicol Chem 24: 820-829.
70. Verhaar HJM, Van Leeuwen CJ, Hermens JLM. 1992. Classifying environmental pollutant. 1: Structure-activity relationships for prediction of aquatic toxicity. Chemosphere 25: 471-491.
71. [VICH] International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. 2000. Environmental impact assessment (EIAs) for veterinary medicinal products (VMPs)-Phase I. VICH Guideline 6 (Ecotoxicity Phase I). London, UK: VICH. CVMP/VICH/592/98-FINAL.
72. [VICH] International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products. 2005. Environmental impact assessment (EIAs) for veterinary medicinal products (VMPs)-Phase II Guidance. VICH Guideline 38 (Ecotoxicity Phase II). London, UK: VICH. CVMP/VICH/790/03-FINAL.
73. Westall JC, Johnson CA, Zhang W. 1990. Distribution of LiCl, NaCl, KCl, HCl, MgCl2, and CaCl2 between octanol and water. Environ Sci Technol 24: 1803-1810.
74. Winter MJ, Owen SF, Murray-Smith R, Panter GH, Hetheridge MJ, Kinter LB. 2010. Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: concepts, considerations and challenges. Integr Environ Assess Manag. 6: 38-51.